Data Foundry

Drug recalls 2026

Telmisartan and Amlodipine — Class III drug recall D-0049-2027

Ongoing recall by Viatris, Inc., reported 2026-10-28, distributed nationwide. Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications

Recall numberD-0049-2027
Product typeDrug
ClassificationClass III
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmViatris, Inc., Morgantown, WV, United States
Recall initiated2026-10-01
Classified2026-10-16
Reported by FDA2026-10-28
DistributedNationwide (US)
Reason classespotency
NDC00378-1075, 00378-1075-93, 00378-1076, 00378-1076-93, 00378-1077, 00378-1077-93, 00378-1078, 00378-1078-93
Lot numbers3228113, 3228114, 3228115, 3228120, 3228121
Expiration dates2026-10-31, 2026-11-30

Product

Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.

Reason for recall

Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0049-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-03. Not affiliated with or endorsed by FDA. Not medical or legal advice.